Determining research priorities for clinician-initiated trials in infectious diseases

David PATERSON; Allen Cheng; A Peleg; Benjamin Howden; David Murdoch; Emma S. McBryde; Ian Woolley; Joshua Davis; Louise Cooley; Monica Slavin; James Robinson; Ronan Murray; Sharon Chen; Tania C Sorrell; Tony Walls; N Bak; Anna Ralph; Sally Havers; Tiffany Brown

doi:10.5694/mja12.11703

Determining research priorities for clinician-initiated trials in infectious diseases

David PATERSON, Allen Cheng, A Peleg, Benjamin Howden, David Murdoch, Emma S. McBryde, Ian Woolley, Joshua Davis, Louise Cooley, Monica Slavin, James Robinson, Ronan Murray, Sharon Chen, Tania C Sorrell, Tony Walls, N Bak, Anna Ralph, Sally Havers, Tiffany Brown

Global and Tropical Health

Research output: Contribution to journal › Comment/debate

Abstract

Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).
Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.
Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.
Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.
Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.

Original language	English
Pages (from-to)	270-272
Number of pages	3
Journal	Medical Journal of Australia
Volume	198
Issue number	5
DOIs	https://doi.org/10.5694/mja12.11703
Publication status	Published - 2013

Access to Document

10.5694/mja12.11703

Cite this

PATERSON, D., Cheng, A., Peleg, A., Howden, B., Murdoch, D., McBryde, E. S., Woolley, I., Davis, J., Cooley, L., Slavin, M., Robinson, J., Murray, R., Chen, S., Sorrell, T. C., Walls, T., Bak, N., Ralph, A., Havers, S., & Brown, T. (2013). Determining research priorities for clinician-initiated trials in infectious diseases. Medical Journal of Australia, 198(5), 270-272. https://doi.org/10.5694/mja12.11703

@article{5992313e65d9424b8e560248aec43640,

title = "Determining research priorities for clinician-initiated trials in infectious diseases",

abstract = "Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.",

author = "David PATERSON and Allen Cheng and A Peleg and Benjamin Howden and David Murdoch and McBryde, {Emma S.} and Ian Woolley and Joshua Davis and Louise Cooley and Monica Slavin and James Robinson and Ronan Murray and Sharon Chen and Sorrell, {Tania C} and Tony Walls and N Bak and Anna Ralph and Sally Havers and Tiffany Brown",

year = "2013",

doi = "10.5694/mja12.11703",

language = "English",

volume = "198",

pages = "270--272",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "Australasian Medical Publishing Company",

number = "5",

}

PATERSON, D, Cheng, A, Peleg, A, Howden, B, Murdoch, D, McBryde, ES, Woolley, I, Davis, J, Cooley, L, Slavin, M, Robinson, J, Murray, R, Chen, S, Sorrell, TC, Walls, T, Bak, N, Ralph, A, Havers, S & Brown, T 2013, 'Determining research priorities for clinician-initiated trials in infectious diseases', Medical Journal of Australia, vol. 198, no. 5, pp. 270-272. https://doi.org/10.5694/mja12.11703

TY - JOUR

T1 - Determining research priorities for clinician-initiated trials in infectious diseases

AU - PATERSON, David

AU - Cheng, Allen

AU - Peleg, A

AU - Howden, Benjamin

AU - Murdoch, David

AU - McBryde, Emma S.

AU - Woolley, Ian

AU - Davis, Joshua

AU - Cooley, Louise

AU - Slavin, Monica

AU - Robinson, James

AU - Murray, Ronan

AU - Chen, Sharon

AU - Sorrell, Tania C

AU - Walls, Tony

AU - Bak, N

AU - Ralph, Anna

AU - Havers, Sally

AU - Brown, Tiffany

PY - 2013

Y1 - 2013

N2 - Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.

AB - Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.

U2 - 10.5694/mja12.11703

DO - 10.5694/mja12.11703

M3 - Comment/debate

SN - 0025-729X

VL - 198

SP - 270

EP - 272

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 5

ER -

Determining research priorities for clinician-initiated trials in infectious diseases

Abstract

Access to Document

Fingerprint

Cite this